Shareholders of Amedisys Inc. (NASDAQ: AMED) have voted in favor of the company’s pending acquisition by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. Optum in June penned a deal to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion. The transaction followed a previous offer to acquire Amedisys by the […]
The Future Leaders Awards program is brought to you in partnership with Homecare Homebase. The program is designed to recognize up-and-coming industry members who are shaping the next decade of home health, hospice care, senior housing, skilled nursing, and behavioral health. To see this year’s Future Leaders, visit https://futureleaders.agingmedia.com/. Drake Jarman, senior vice president of […]
Amedisys’ New Chief Accounting Officer The forthcoming acquisition of Amedisys, Inc. (NASDAQ: AMED) by UnitedHealth Group (NYSE: UNH) subsidiary Optum has sparked executive shifts. The home health and hospice provider recently announced the leadership changes in a filing with the U.S. Securities & Exchange Commission (SEC). Allyson Guidroz was recently appointed as its chief accounting […]
Negotiations around Amedisys Inc.’s (NASDAQ: AMED) Contessa subsidiary were a significant contributor to the pendulum swing that led to the company’s acquisition by UnitedHealth Group’s (NYSE: UNH) Optum rather than Option Care Health (NASDAQ: OPCH). Optum in June penned its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 […]
Thus far in 2023, hospice merger and acquisition activity has deviated from prior years. This year is distinctive because of factors such as valuations, asset sizes and the mix of buyers. A number of trends have shifted. The last five years saw record-breaking multiples in the hospice space and private equity-backed platform deals were among […]
Enhabit Inc. (NYSE: EHAB) has confirmed that it will begin considering “strategic alternatives” that could include a potential sale or merger. The Dallas-based home health and hospice provider announced today that it had satisfied the conditions of its Tax Matters Agreement (TMA) with its former parent company Encompass Health (NYSE: EHC). Enhabit emerged from the […]
The U.S. Department of Justice (DOJ) will investigate potential antitrust violations in the UnitedHealth Group (NYSE: UNH) subsidiary Optum’s forthcoming acquisition of Amedisys, Inc. (NASDAQ: AMED). To date, neither Amedisys nor Optum have been accused of any wrongdoing. The DOJ performed a similar investigation when Optum acquired the health care technology company Change Healthcare earlier this […]
Enhabit Inc. (NYSE: EHAB) has announced plans to launch a strategic review process that could result in a potential sale. The consideration marks another move among large home health and hospice providers in the industry. The company is getting ready to explore various transaction options in order to satisfy the terms of its Tax Matters […]
High-acuity care in the home has become an admissions growth engine for Amedisys (NASDAQ: AMED), which the company delivers through its subsidiary Contessa. Combined, hospital-at-home and skilled nursing facility-at-home admissions grew by 55% year-over-year during the second quarter of the year. This is compared to a 4% increase in home health same-store admissions and a […]
Regulatory challenges have contributed to the hospice sector’s current M&A slump, but this year’s volume nevertheless aligns with experts’ forecasts. In addition to those pressures, the industry is also in a cooling period in which companies focus on integrating the assets that many acquired during flurries of activity in 2021 and 2022, according to Mark […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
